Study on Clinical Value of Vitamin D in Recurrent Spontaneous Abortion
NCT ID: NCT06002035
Last Updated: 2023-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1421 participants
OBSERVATIONAL
2021-01-01
2023-07-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants, who visit the RSA specialty clinic, will provide medical history information, regularly exam based on the condition, following up on pregnancy status.Participants will be asked to supply vitamin D preparation and do moderate exercise outdoors, comparing the effect after treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Cohort Study of the Correlation Between Serum 25(OH)D Level and Pregnancy Outcome
NCT05824897
Correlation of Vitamin D Levels in Early Pregnancy With Gestational Diabetes and Pregnancy Outcomes
NCT05212519
Association Between Vitamin D and the Risk of Uterine Fibroids
NCT03586947
Vitamin D and Angiogenic Markers in Odense Child Cohort 1
NCT02434900
The Effect of Vitamin D on in Vitro Fertilization Outcome
NCT02361827
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients without spontaneous abortion(SA0)
The patients with VD deficiency or insufficiency take 30 drops (relative to 1ml) once a day, directly into the mouth or with complementary foods added.
Binom Vitamin D drops
Take 30 drops (relative to 1ml) once a day, directly into the mouth or with complementary foods added
patients with a spontaneous abortion(SA1)
The patients with VD deficiency or insufficiency take 30 drops (relative to 1ml) once a day, directly into the mouth or with complementary foods added.
Binom Vitamin D drops
Take 30 drops (relative to 1ml) once a day, directly into the mouth or with complementary foods added
patients with RSA (SA2 and above)
The patients with VD deficiency or insufficiency take 30 drops (relative to 1ml) once a day, directly into the mouth or with complementary foods added.
Binom Vitamin D drops
Take 30 drops (relative to 1ml) once a day, directly into the mouth or with complementary foods added
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Binom Vitamin D drops
Take 30 drops (relative to 1ml) once a day, directly into the mouth or with complementary foods added
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of patients with a spontaneous abortion;
* Clinical diagnosis of patients with recurrent pontaneous abortions;
Exclusion Criteria
* Patients who take VD preparations or related VD supplements within 3 months before treatment;
* Patients with a combination of certain malignant tumors and severe mental illness.
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jianmei Xia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jianmei Xia
Deputy Chief Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jianmei Xia
Role: STUDY_DIRECTOR
First People's Hospital of Hangzhou
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jianmei Xia
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.